Ghana’s healthcare system currently lacks sufficient Positron Emission Tomography-Computed Tomography (PET-CT) scanners, a critical tool for cancer diagnosis. A new PET-CT scanner costs between $1 million and $1.9 million USD when fully installed. This amount is equivalent to the price of 15 to 25 luxury V8 vehicles.
This significant disparity highlights a fundamental question about national expenditure priorities. While a fleet of V8 vehicles serves political and official transport needs, a PET-CT scanner offers life-saving early cancer detection. The increasing number of cancer cases in Ghana, including breast, cervical, prostate, liver, and colorectal cancers, underscores the urgent need for such medical technology.
This situation fits into a broader national debate on government spending and infrastructure development. Ghana often prioritises highly visible projects and procurements over less obvious but equally vital public services like advanced healthcare. Historically, arguments against acquiring advanced medical equipment often cite high costs. However, critics now argue this justification is weak compared to other national expenditures. The country's aspiration to be a West African leader requires an advanced healthcare system, not just symbolic developments.
The MyJoyOnline report questions the perception of affordability when comparing a PET-CT scanner to luxury vehicles. It states, “The cost of one PET-CT machine may appear high initially, but the long-term benefits are enormous.” These benefits include reducing medical tourism, improving survival rates, fostering local specialist training, and creating healthcare jobs. Furthermore, revenue generation from regional patients seeking treatment could contribute to the economy.
A critical decision point now faces Ghanaian policymakers. The rise in cancer cases and increasing healthcare demands necessitate a bold investment in life-saving technologies. Prioritising such equipment would reduce the burden on families forced to seek medical care abroad. Furthermore, it would strengthen Ghana’s medical reputation and attract patients from neighbouring countries. Market watchers and medical professionals will closely observe any government commitments to address this diagnostic capacity gap.
The lack of domestic PET imaging capacity forces many patients to seek diagnosis and treatment abroad. Countries like India, South Africa, and Turkey become essential destinations for Ghanaians. Families frequently liquidate assets, organise public fundraising campaigns, or rely on government sponsorships to finance overseas treatment. This outflow of funds and talent represents a significant economic and social cost to the nation.
Investing in PET-CT technology would not only improve patient outcomes but also create a hub for medical expertise. It would support radiation therapy planning and reduce the overall cost burden on the healthcare system. The sustained absence of sufficient PET-CT scanners puts Ghana at a disadvantage compared to other developing nations investing in modern medical infrastructure. The true question is no longer affordability, but national priority.